Taiwan · Delayed Price · Currency is TWD We Can Medicines Statistics
Total Valuation
TPEX:6929 has a market cap or net worth of TWD 975.72 million. The enterprise value is 1.95 billion.
| Market Cap | 975.72M |
| Enterprise Value | 1.95B |
Important Dates
The next estimated earnings date is Friday, August 7, 2026.
| Earnings Date | Aug 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TPEX:6929 has 45.07 million shares outstanding. The number of shares has increased by 0.99% in one year.
| Current Share Class | 45.07M |
| Shares Outstanding | 45.07M |
| Shares Change (YoY) | +0.99% |
| Shares Change (QoQ) | -0.01% |
| Owned by Insiders (%) | 0.64% |
| Owned by Institutions (%) | n/a |
| Float | 5.08M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.30 |
| PB Ratio | 0.95 |
| P/TBV Ratio | 0.95 |
| P/FCF Ratio | 3.80 |
| P/OCF Ratio | 3.28 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.49, with an EV/FCF ratio of 7.60.
| EV / Earnings | -27.74 |
| EV / Sales | 0.61 |
| EV / EBITDA | 10.49 |
| EV / EBIT | n/a |
| EV / FCF | 7.60 |
Financial Position
The company has a current ratio of 1.49, with a Debt / Equity ratio of 1.19.
| Current Ratio | 1.49 |
| Quick Ratio | 0.53 |
| Debt / Equity | 1.19 |
| Debt / EBITDA | 6.58 |
| Debt / FCF | 4.77 |
| Interest Coverage | -2.68 |
Financial Efficiency
Return on equity (ROE) is -6.59% and return on invested capital (ROIC) is -3.42%.
| Return on Equity (ROE) | -6.59% |
| Return on Assets (ROA) | -1.42% |
| Return on Invested Capital (ROIC) | -3.42% |
| Return on Capital Employed (ROCE) | -3.39% |
| Weighted Average Cost of Capital (WACC) | 1.57% |
| Revenue Per Employee | 3.16M |
| Profits Per Employee | -69,021 |
| Employee Count | 1,020 |
| Asset Turnover | 1.08 |
| Inventory Turnover | 2.56 |
Taxes
In the past 12 months, TPEX:6929 has paid 18,000 in taxes.
| Income Tax | 18,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -36.97% in the last 52 weeks. The beta is -0.50, so TPEX:6929's price volatility has been lower than the market average.
| Beta (5Y) | -0.50 |
| 52-Week Price Change | -36.97% |
| 50-Day Moving Average | 27.53 |
| 200-Day Moving Average | 30.75 |
| Relative Strength Index (RSI) | 22.73 |
| Average Volume (20 Days) | 19,881 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:6929 had revenue of TWD 3.22 billion and -70.40 million in losses. Loss per share was -1.56.
| Revenue | 3.22B |
| Gross Profit | 1.06B |
| Operating Income | -67.75M |
| Pretax Income | -70.38M |
| Net Income | -70.40M |
| EBITDA | -1.92M |
| EBIT | -67.75M |
| Loss Per Share | -1.56 |
Balance Sheet
The company has 247.20 million in cash and 1.22 billion in debt, with a net cash position of -977.00 million or -21.68 per share.
| Cash & Cash Equivalents | 247.20M |
| Total Debt | 1.22B |
| Net Cash | -977.00M |
| Net Cash Per Share | -21.68 |
| Equity (Book Value) | 1.03B |
| Book Value Per Share | 22.83 |
| Working Capital | 448.08M |
Cash Flow
In the last 12 months, operating cash flow was 297.52 million and capital expenditures -40.71 million, giving a free cash flow of 256.81 million.
| Operating Cash Flow | 297.52M |
| Capital Expenditures | -40.71M |
| Depreciation & Amortization | 65.82M |
| Net Borrowing | -198.66M |
| Free Cash Flow | 256.81M |
| FCF Per Share | 5.70 |
Margins
Gross margin is 33.00%, with operating and profit margins of -2.10% and -2.19%.
| Gross Margin | 33.00% |
| Operating Margin | -2.10% |
| Pretax Margin | -2.19% |
| Profit Margin | -2.19% |
| EBITDA Margin | -0.06% |
| EBIT Margin | -2.10% |
| FCF Margin | 7.97% |
Dividends & Yields
TPEX:6929 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.99% |
| Shareholder Yield | -0.99% |
| Earnings Yield | -7.22% |
| FCF Yield | 26.32% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |